Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients.
Saved in:
| Title: | Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients. |
|---|---|
| Authors: | Hojbjerg JA; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark. Electronic address: johanand@rm.dk., Ebert EBF; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Clement MS; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark., Winther-Larsen A; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark., Meldgaard P; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Sorensen B; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark. |
| Source: | Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2019 Sep; Vol. 135, pp. 92-96. Date of Electronic Publication: 2019 Jul 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1872-8332 |
|---|---|
| DOI: | 10.1016/j.lungcan.2019.07.005 |
